A randomized clinical trial of age and genotype-guided tacrolimus dosing after pediatric solid organ transplantation-Reference-Cited by-同舟云学术

A randomized clinical trial of age and genotype-guided tacrolimus dosing after pediatric solid organ transplantation

Published:2018-09-03 Issue:7 Volume:22 Page:e13285
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplant

Author:

Min Sandar¹^ORCID,Papaz Tanya¹,Lafreniere-Roula Myriam¹,Nalli Nadya²,Grasemann Hartmut¹,Schwartz Steven M.³,Kamath Binita M.¹,Ng Vicky⁴,Parekh Rulan S.¹⁵⁶,Manlhiot Cedric⁷,Mital Seema¹^ORCID

Affiliation:

1. Department of Pediatrics; Hospital for Sick Children; University of Toronto; Toronto Ontario Canada

2. Department of Pharmacy; Hospital for Sick Children; University of Toronto; Toronto Ontario Canada

3. Department of Cardiac Critical Care Medicine; Hospital for Sick Children; University of Toronto; Toronto Ontario Canada

4. Transplant and Regenerative Medicine Centre; Department of Pediatrics; Hospital for Sick Children; University of Toronto; Toronto Ontario Canada

5. Division of Nephrology; Department of Medicine; University Health Network and University of Toronto; Toronto Ontario Canada

6. Child Health Evaluative Sciences Program; SickKids Research Institute; Toronto Ontario Canada

7. Cardiovascular Data Management Centre (CVDMC) Hospital for Sick Children; University of Toronto; Toronto Ontario Canada

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/petr.13285/fullpdf

Reference31 articles.

1. Tacrolimus blood level fluctuation predisposes to coexisting BK virus nephropathy and acute allograft rejection;Shen;Sci Rep,2017

2. High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation;Borra;Nephrol Dial Transplant,2010

3. Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure;Sapir-Pichhadze;Kidney Int,2014

4. Tacrolimus-related adverse effects in liver transplant recipients: its association with trough concentrations;Varghese;Indian J Gastroenterol,2014

5. Mechanisms of clinically relevant drug interactions associated with tacrolimus;Christians;Clin Pharmacokinet,2002

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the evidence for genotype‐informed Bayesian dosing of tacrolimus in children undergoing solid organ transplantation: A systematic literature review;British Journal of Clinical Pharmacology;2024-08-15

2. A descriptive study of the single-nucleotide polymorphisms known to affect the Tacrolimus trough concentration per dose, among a population of kidney failure patients in a tertiary hospital in Ghana;BMC Research Notes;2024-07-29

3. Population pharmacokinetic models of tacrolimus in paediatric solid organ transplant recipients: A systematic review;British Journal of Clinical Pharmacology;2023-10-04

4. A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction;Kidney International;2023-10

5. CYP3A4 and CYP3A5 Genotyping Recommendations;The Journal of Molecular Diagnostics;2023-09